We use cookies to make it easier for you to use our website and give you a better experience. We aggregate the information we get through cookies from users like you, and analyze that data to better understand user behavior and help us improve the website. We do not give or sell the data you provide through cookies to any third party for any purpose (such as advertising or marketing). By using this website, you consent to Organogenesis using cookies for these purposes. You may change your settings anytime by clicking on the “Security” tab on your browser. Note that Organogenesis is located in the United States, and the U.S. has not yet been determined to have “adequate” data privacy safeguards by the EU; despite any inherent risks in the transfer of data from the EU, Organogenesis takes the security of your information seriously. To read our privacy policy, click here.
Apligraf® Contact UsApligraf® ContactApligraf® Website Feedback

If you have any comments concerning the content on this website, including ideas for additional information, we would like to hear from you. Simply put your comment(s) in the feedback form below.

All fields marked with an asterisk * are required.

First name:*
Last name:
E-mail:
State:
Age:
Comments:*  
Enter code shown
in the picture
on the right:*
(not case sensitive)
To Enlarge Click on Image
 
Click to enlarge this image
Display different code
 
Submit

References:

3. Falanga V, Sabolinski ML. A bilayered living skin construct (Apligraf®) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen. 1999;7:201-207.

4. Veves A, Falanga V, et al. Graftskin, a human skin equivalent, is effective in management of non-infected neuropathic diabetic foot ulcers. Diabetes Care. 2001;24:290-295